SCHEMBL6943848

SCHEMBL6943848

CCOC(=O)N1C2CCC1CC(=Cc1ccc(Cl)cc1)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.43
HTT P42858 1/20 0.42
CHRM1 P11229 2/20 0.41
KCNK3 O14649 1/20 0.41
KCNK9 Q9NPC2 1/20 0.41
AKR1C3 P42330 1/20 0.40
AKR1C1 Q04828 1/20 0.40
ALDH1A1 P00352 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
MITF O75030 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
KDM4E B2RXH2 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5870689 0.85 CHRM2 (0.47) CHRM1KCNK3KCNK9MEN1KMT2A
SCHEMBL7330055 0.77 MEN1 (0.37) CHRM1ALDH1A1MEN1KMT2ALMNA
SCHEMBL6939247 0.76 AKR1C3 (0.43) PPARGHTTAKR1C3AKR1C1ALDH1A1
SCHEMBL6939248 0.76 AKR1C3 (0.43) PPARGHTTAKR1C3AKR1C1ALDH1A1
SCHEMBL13791959 0.74 HTR2C (0.49) CYP2C19MEN1KMT2ALMNASMN1; SMN2
SCHEMBL3132747 0.74 CHRM1 (0.38) CHRM1
SCHEMBL6945954 0.73 CHRM1 (0.47) CHRM1ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL3888021 0.72 CHRM2 (0.47) HTTCHRM1MEN1KMT2ALMNA
SCHEMBL5870650 0.72 CHRM2 (0.44) CHRM1ALDH1A1
SCHEMBL1016674 0.71 CHRM1 (0.42) CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1244450-A4 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2003-03-19 EP disclosed
EP-1244450-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-10-02 EP disclosed
US-6432976-B1 ANALGESICS; SIDE EFFECT REDUCTION MERCK & CO., INC. 2002-08-13 US disclosed
WO-2001032179-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO disclosed